These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 24301422)

  • 1. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
    Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
    Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
    Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
    Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Chen QJ; Yang YN; Ma YT; Li XM; Xu R; Zhai H; Liu F; Chen BD; Zhao Q
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):5-12. PubMed ID: 26258675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
    Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.
    Cuculi F; Herring N; De Caterina AR; Banning AP; Prendergast BD; Forfar JC; Choudhury RP; Channon KM; Kharbanda RK
    Heart; 2013 Aug; 99(16):1198-203. PubMed ID: 23403409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.